Caxton Associates (New York)’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,612
| Closed | -$207K | – | 498 |
|
|
2024
Q3 | $207K | Sell |
8,612
-8,423
| -49% | -$202K | 0.01% | 481 |
|
|
2024
Q2 | $339K | Buy |
17,035
+2,034
| +14% | +$40.5K | 0.01% | 389 |
|
|
2024
Q1 | $299K | Sell |
15,001
-16,418
| -52% | -$327K | 0.02% | 382 |
|
|
2023
Q4 | $705K | Buy |
31,419
+7,147
| +29% | +$160K | 0.04% | 272 |
|
|
2023
Q3 | $491K | Buy |
+24,272
| New | +$491K | 0.07% | 247 |
|
|
2023
Q2 | – | Sell |
-10,633
| Closed | -$316K | – | 497 |
|
|
2023
Q1 | $316K | Sell |
10,633
-2,475
| -19% | -$73.6K | 0.05% | 339 |
|
|
2022
Q4 | $355K | Buy |
13,108
+2,048
| +19% | +$55.4K | 0.02% | 283 |
|
|
2022
Q3 | $241K | Buy |
+11,060
| New | +$241K | 0.03% | 351 |
|